References
- Haltalin K C, Nelson J D, Ring R, III, Sladoje M, Hinton L V. Double blind treatment study of shigellosis comparing ampicillin, sulfadiazine and placebo. J Pediatr 1967; 70: 970–981
- Salam M A, Bennish M L. Therapy of shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis. J Pediatr 1988; 113: 901–907
- Salam M A, Bennish M L. Antimicrobial therapy for shigellosis. Rev Infect Dis 1991; 13(Suppl 4)332–341
- Molla A M, Molla A M. Effect of antibiotics on food intake and absorption of nutrients for children with diarrhea due to shigella. Rev Infect Dis 1991; 13(Suppl 4)S347–350
- Murray B E. Resistance of shigella, Salmonella, and other selected enteric pathogens to antimicrobial agents. Rev Infect Dis 1986; 8(Suppl 2)S172–181
- Hansson H D, Walder M, Juhlin I. Susceptibility of shigellae to mecillinam, nalidixic acid, trimethoprim, and five other antimicrobial agents. Antimicrob Agents Chemother 1981; 19: 271–273
- Kabir I, Rahaman M M, Ahmed S M, Akhter S Q, Butler T. Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis. Antimicrob Agents Chemother 1984; 25: 643–645
- Barry A L, Thornsberry C. Susceptibility test and diffusion test procedures. Manual of clinical microbiology, E H Lennette, A Balows, W Husler, Jr., H Shadomy. American Society for Microbiology, Washington DC 1985; 978–987
- Bennish M L, Salam M A, Hossain M A. Program Abstr. 31st ICAAC, Abstract 524. 1991
- DeWitt T G, Humphrey K F, McCarthy P. Clinical predictors of acute bacterial diarrhea. Pediatrics 1985; 76: 551–556
- Harris J C, DuPont H L, Hornick R B. Fecal leukocytes in diarrheal illness. Ann Intern Med 1972; 76: 687–703
- Pickering L K, DuPont H L, Olarte J, Conklin R, Ericsson C E. Fecal leukocytes in enteric infectious. Am J Clin Pathol 1977; 68: 562–565
- Kelly M, Brenner D, Farmer J. Enterobacteriaceae. Manual of clinical microbiology, E H Lennette, A Balows, W Hausler, Jr., H Shadomy. American Society for Microbiology, Washington DC 1985; 263–277
- Haltalin K C, Nelson J D, Kusmiesz H T, Hinton L V. Optimal dosage of ampicillin for shigellosis. J Pediatr 1969; 74: 626–631
- Varsano I, Eidlitz-Marcus T, Nussinovitch M, Elian I. Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children. J Pediatr 1991; 118: 627–632
- Buchbinder M, Webb J C, Anderson L V, McCabe W R. Laboratory studies and clinical pharmacology of nalidixic acid (WIN 18,320). Antimicrobial agents and chemotherapy – 1962, J C Sylvester. American Society for Microbiology, Ann Harbor, Michigan 1963; 308–317
- Kabir I, Butler T, Khanam A. Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in a placebo-controlled trial. Antimicrob Agents Chemother 1986; 29: 645–648
- Prado D, Lopez E, Liu H, Devoto S, Woloj M, Contrini M, Murray B E, Gomez H, Cleary T G. Efficacy of ceftibuten in the treatment of bacillary dysentery. Pediatr Infect Dis J 1992; 11: 644–647
- Spratt B G. The mechanism of action of mecillinam. J Antimicrob Chemother 1977; 3(Suppl B)13–19
- Tybring L, Melchior N H. Mecillinam (FL 1060), a 6-b˜-amidino-penicillanic acid derivative: bactericidal action and synergy in vitro. Antimicrob Agents Chemother 1975; 8: 271–276